Press Releases on January 4, 2024 - EIN Presswire - Press Release Distribution Service

Published on January 4, 2024 - 13:00 GMT

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary ...

CAMBRIDGE, Mass. and NESS ZIONA, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced …

Distribution channels: Politics, Technology ...

Published on January 4, 2024 - 13:00 GMT

Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference

CHARLESTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive …

Distribution channels:

Published on January 4, 2024 - 13:00 GMT

Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates

BOTHELL, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) provides an update on the clinical development of its oral first-in-class pan-norovirus and pan-coronavirus dual protease inhibitor CDI- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 4, 2024 - 13:00 GMT

TransUnion Announces Enhanced Identity Graph for Marketing Solutions

CHICAGO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) announced today the enhancement of its TruAudience® marketing solutions line with the newly improved TransUnion identity graph that delivers more accurate identity resolution and robust …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

Chris brings extensive enterprise-level leadership experience in business development, commercial operations, and corporate strategy IND-enabling toxicology studies of THB335 nearing completion; Pre-IND interaction with the U.S. FDA now complete Program …

Distribution channels:

Published on January 4, 2024 - 13:00 GMT

Microscoop From Syncell Named “Proteomics Innovation Of The Year” By BioTech Breakthrough

TAIPEI, Taiwan and LOS ALTOS, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Syncell, a life science tools company pioneering the technology of microscopy-guided proteomics discovery, today announced that its Microscoop has been selected as “Proteomics …

Distribution channels: Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

TCDI Selected As 2023 “Overall eDiscovery Solution Provider of the Year” By LegalTech Breakthrough

LOS ANGELES, Jan. 04, 2024 (GLOBE NEWSWIRE) -- LegalTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout legal technology companies, products and services around the globe, today announced that …

Distribution channels: Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

Well+Good Launches Well/Mess: A New Approach to January Wellness

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Well+Good, a leading health and wellness media brand, announced today the launch of its annual New Year’s wellness program: Well/Mess, to help readers kick off their year with intention. The program is an ode to …

Distribution channels: Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

Constellium to Showcase Cutting-Edge Solutions for Aluminium Automotive Structures at CES 2024 in Las Vegas

PARIS, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Constellium (NYSE: CSTM) will exhibit its latest innovations in aluminium Automotive Structures at CES 2024 in Las Vegas from January 9-12. A leading supplier of advanced lightweight aluminium automotive components, …

Distribution channels:

Published on January 4, 2024 - 13:00 GMT

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data anticipated in the 2nd half of 2024 - - IND application filed for conditionally activated EpCAM-directed ADC (CX-2051) with Phase 1 initiation in EpCAM positive tumors expected in the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

Viracta Therapeutics Provides Clinical Update and Outlook for 2024

Speed to market strategy for Nana-val in patients with relapsed or refractory EBV+ peripheral T-cell lymphoma supported by complete enrollment of Stage 1, complete enrollment of Stage 2 anticipated in Q1 2024 and engagement with the FDA on potential …

Distribution channels: Technology ...

Published on January 4, 2024 - 13:00 GMT

Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual Conference

Abstracts highlight the serious clinical burden of uncontrolled NASH and identify opportunities to improve patient care In an analysis of patient records from a large claims database, the risk of progressing to cirrhosis, decompensated cirrhosis, liver …

Distribution channels:

Published on January 4, 2024 - 13:00 GMT

Casa Systems Appoints Former Google Executive Santanu Dasgupta as Chief Technology Officer

ANDOVER, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Casa Systems (Nasdaq: CASA), a market leader in cloud-native network solutions serving Tier 1 and regional service providers worldwide, today announced the appointment of telecom industry leader Santanu …

Distribution channels:

Published on January 4, 2024 - 13:00 GMT

DIRTT and SourceBlue Announce Strategic Alliance to Transform the Interior Construction Procurement Process

CALGARY, Alberta, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DIRTT, a leading provider of innovative interior construction solutions, and SourceBlue, a division of Turner Construction, announced a strategic alliance today. Known for creating flexible and agile …

Distribution channels: Companies, Energy Industry ...

Published on January 4, 2024 - 13:00 GMT

Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic ...

FARMINGTON HILLS, Mich., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 4, 2024 - 13:00 GMT

Super League to Host Virtual Non-Deal Roadshow Webinar on Wednesday, January 17, 2024, at 11:00 a.m. Eastern Time

~ Highlights Include 3Q23 Record Revenue of $7.2 Million, Secured Largest Deal to Date of Approximately $4 Million ~ ~ Management Reinforces its Conviction of Profitability in 2024 ~ SANTA MONICA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Super League ( …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on January 4, 2024 - 13:00 GMT

authID Continues Growth Momentum with Strong Q4 Sales

DENVER, Jan. 04, 2024 (GLOBE NEWSWIRE) -- authID® [Nasdaq: AUID], a leading provider of innovative biometric identity verification and authentication solutions, today announced that it signed new customer contracts with gross Booked Annual Recurring …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s ...

SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it has achieved technological proof of concept for DARE-LARC1 and the underlying innovative drug delivery …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 4, 2024 - 13:00 GMT

ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services

WASHINGTON, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ZeroFox (Nasdaq: ZFOX), a leading provider of external cybersecurity, has received $289 million in awards from the U.S. Office of Personnel Management (OPM) for the continued provision of digital identity …

Distribution channels: Companies, IT Industry ...

Published on January 4, 2024 - 13:00 GMT

Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel ...

Pleasanton, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTCQB) PK: PKBO), announced that it was awarded US Patent No. 11,691,982 B2 entitled “Thailanstatin Analogs” by The United States Patent and …

Distribution channels: